Skip to main content
Psoriatic Arthritis ICYMI
FULL MENU
FULL MENU
Presented by
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
Crosswords
Psoriatic Arthritis Medications
Publish date:
July 26, 2022
Recommended Reading
Commentary: Evaluating New Treatments and Cardiovascular Risk in PsA, July 2022
Psoriatic Arthritis ICYMI
Large study reaffirms rare risk of TNF inhibitor–induced psoriasis in patients with RA, IBD
Psoriatic Arthritis ICYMI
Zoster vaccination does not appear to increase flare risk in patients with immune-mediated inflammatory disease
Psoriatic Arthritis ICYMI
Pain and photophobia
Psoriatic Arthritis ICYMI
Physicians urged to write indications on drug scripts as methotrexate users face new barriers with SCOTUS decision
Psoriatic Arthritis ICYMI
New algorithm for initial PsA treatment choice is driven by T-cell behavior
Psoriatic Arthritis ICYMI
Neural networks can distinguish PsA from rheumatoid arthritis on MRI
Psoriatic Arthritis ICYMI
Methotrexate’s impact on COVID-19 vaccination: New insights made
Psoriatic Arthritis ICYMI
NAFLD strongly correlated with psoriasis, PsA; risk linked to severity
Psoriatic Arthritis ICYMI
Questionnaire for patients with psoriasis might identify risk of axial involvement
Psoriatic Arthritis ICYMI
Psoriatic Arthritis
FULL MENU
FULL MENU
Presented by
FULL MENU
FULL MENU
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge